Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingObservational

Data Collection for Patients With Low Grade Ovarian Carcinoma

NCT ID: NCT00488878Sponsor: M.D. Anderson Cancer CenterLast updated: 2026-02-13

Summary

This study collects information to maintain a database on patients with low-grade ovarian or peritoneal tumors. Collecting information about the type of cancer and treatment, as well as details about follow-up care, may help researchers learn and better understand these tumor types and help develop better treatments for them.

Detailed description

PRIMARY OBJECTIVES: I. To collect, both prospectively and retrospectively, data on disease characterization, treatment, and outcomes for approximately 1600 female patients with low-grade ovarian and peritoneal tumors. II. To organize clinical information in order to support multifaceted queries of patient characteristics, treatment, and disease outcome data and to facilitate correlation of these characteristics with patient outcome. III. To have a single data repository, kept on a secure platform that will integrate clinical information and research findings and serve as a secure archive for future research. SECONDARY OBJECTIVE: I. To obtain and store human tumor samples in the form of blocks or slides for the purpose of establishing a tumor bank. OUTLINE: Patients' medical records are reviewed for retrospective and prospective data collection. Patients may also have residual tissue samples collected and stored.

Arms & interventions

  • ProcedureBiospecimen Collection

    Patients' residual tissue samples are collected

  • OtherElectronic Health Record Review

    Medical records are reviewed

Outcome measures

Primary

  • Prospective and retrospective data collection on disease characterization, treatment, and outcomes

    Time frame: Up to 28 years

  • Organization of clinical information

    Will be done in order to support multifaceted queries of patient characteristics, treatment, and disease outcome data and to facilitate correlation of these characteristics with patient outcome.

    Time frame: Up to 28 years

  • Creation of a single data repository to integrate clinical information and research findings

    Time frame: Up to 28 years

Secondary

  • Collection and storage of human tumor samples for the establishment of a tumor bank

    Time frame: Up to 28 years

Eligibility criteria

Sex: FemaleAge: All agesHealthy volunteers: No
Inclusion Criteria: * Patients whose disease progressed to a higher-grade carcinoma since the time of original diagnosis: * Ovarian tumor of low malignant potential * Low-grade serous carcinoma of the ovary * Primary peritoneal tumor of low malignant potential * Low-grade serous carcinoma of the peritoneum * Psammocarcinoma

Study locations (1)

M D Anderson Cancer Center

Houston, Texas, 77030

Recruiting
David M. Gershenson · Contact
David M. Gershenson · Principal Investigator